SPA17 and idiopathic pulmonary fibrosis: The results showed that the SPA17/GAPDH ratio in the peripheral blood of IPF patients was significantly higher compared with the control group (0.6723 [0.6319–0.9349] vs 1.1903 [1.1441–1.5034], p = 0.0096; Figure 7G).